$BIEL with their Patented Actipatch is entering a 36 billion dollar business with their Migraines clinical trial. THIS IS GOING TO BE HUGE BioElectronics Announces Independent Migraine Clinical Study; Migraine Prevention Using ActiPatch (Pulsed Shortwave Therapy) http://www.otcmarkets.com/stock/BIEL/news/BioElectronics-Announces-Independent-Migraine-Clinical-Study--Migraine-Prevention-Using-ActiPatch--Pulsed-Shortwave-Therapy-?id=160386 http://exploreplasticsurgery.com/bioelectronics-migraine-device-study/